Medicamen Biotech's Sterile injectable Facility Received USFDA Approval: Opening Doors to Regulated Markets Globally.

Medicamen Biotech's Sterile injectable Facility Received USFDA Approval: Opening Doors to Regulated Markets Globally.

• Year: 2024
• November 16, 2024

We’re excited to announce that our Sterile Oncology Facility is now USFDA approved, enabling us to expand into regulated markets like the US and the Middle East. This milestone reflects our commitment to delivering high-quality oncology treatments globally, supporting patients with advanced, compliant options.